Skin cancer drug recommended for routine NHS use
An appeal period has now opened until 26 February 2021.
-
NICE recommends treatment options for severe pregnancy sickness in new draft guidance
Nausea and vomiting, often referred to as morning sickness, is common in pregnancy. Close to 80% of pregnant women experience these symptoms, with most conditions improving or stopping completely by around 16 to 20 weeks.
-
NICE’s processes of technology evaluation - presenting a case for change
NICE has today (4 February 2021) launched a public consultation on proposals for changes to the processes it uses to develop its guidance on medicines, medical devices, diagnostics and digital health technologies.
-
Thousands of lung cancer patients to benefit from life-extending treatment
A potentially life-extending treatment for some people with non-squamous, non-small-cell lung cancer (NSCLC) will now be available on the NHS following its approval by NICE in draft guidance published today.
